News and Trends 4 Aug 2022
PolyPid to receive millions for commercialization of infection-fighting drug
A drug to prevent surgical site infections (SSIs) in abdominal and cardiac surgeries in Europe is to be commercialized after two companies entered an exclusive licensing agreement. Israel-based PolyPid Ltd…